AS210418
Xellia Pharmaceuticals ApS
Reputation · trust score
A transparent 0–100 signal. Every entity starts at a neutral baseline of 65; threat-intel blocklists, exposure, reverse-DNS, routing and allocation each adjust it up or down. Higher is more trustworthy.
- Baseline (neutral) 65
- Trust score 65 / 100
Experimental · trust-vectors model v1.2.0 — a transparent heuristic, not a definitive verdict. How it works →
Top CIDR ranges
| CIDR | IPs | PTR Density | Organization | Country | State | City |
|---|---|---|---|---|---|---|
| 94.143.227.0/24 | 256 |
0.0%
|
Xellia Pharmaceuticals ApS | DK | — | — |
BGP Announced Prefixes
Live BGP anomalies →Prefixes AS210418 actually originates in BGP, observed across our RIPE RIS collectors. This live routing view can differ from the registry allocation above.
| Prefix | Announcement samples | Last seen |
|---|---|---|
| 94.143.227.0/24 | 8,620 | 2026-07-26 20:18:57 |
Frequently Asked Questions
What is AS210418?
AS210418 is an Autonomous System Number assigned to Xellia Pharmaceuticals ApS. An ASN identifies a network that controls a specific set of IP addresses and determines how traffic is routed across the internet via BGP (Border Gateway Protocol).
How many IP addresses does AS210418 announce?
AS210418 announces 256 IPv4 addresses distributed across 1 routed CIDR prefixes. The network is registered in Denmark.
Who operates AS210418?
AS210418 is operated by Xellia Pharmaceuticals ApS. The organization is based in Denmark. You can view all IP ranges and related ASNs on the organization page.
What country is AS210418 registered in?
AS210418 is registered in Denmark. This indicates where the network operator is headquartered, though the IP addresses it announces may serve users globally.
